Dyslipidemia Flashcards
High cholesterol is a major risk factor for
Coronary heart disease
Lipid categories
Cholesterol
Cholesterol esters
TGs
Phospholipids
Lipoproteins
LDLs
HDLs
VLDLs
Apolipoproteins
ApoB
ApoA1
ApoCIII
Pathogenesis of atherosclerosis
Endothelial injury
Inflammatory response
Macrophage infiltration
Platelet adhesion
Smooth muscle cell proliferation
Extracellular matrix accumulation
Dyslipidemia common symptoms
Usually asymptomatic
Dyslipidemia severe symptoms
Chest pain, anxiety, SOB, lose consciousness, abdominal pain, sudden death
Signs of dyslipidemia
Pancreatitis
Eruptive xanthomas
Increased BP, waist size, BMI
Lab presentation of dyslipidemia
Increased:
Non-HDL (LDL, TG, TC)
ApoB
LDL-P
Decreased:
HDL
AHA approved non-fasted lipid panel if…
Measuring initial risk
Pt not on lipid lowering tx
Pt doesn’t have family hx of genetic hyperlipidemia
Pt TGs are low
FLP includes…
TC
TG
HDL
LDL
Friedewald equation
LDL = TC - HDL - TG/5
Not valid if TG > 400
Lifestyle management of dyslipidemia
DASH diet, reduce saturated/trans fat, lower sodium, engage in moderate-low intensity workouts, increasing soluble fiber can decrease LDLs
Dyslipidemia medication options
Statins
Bile acid resins
Niacin
Cholesterol absorption inhibitors
Fibrates
PCSK9 inhibitors
Inclisiran
Bempedoic acid
HMG-CoA reductase inhibitors
Lovastatin
Pravastatin
Pitavastatin
Simvastatin
Fluvastatin
Atorvastatin
Rosuvastatin
Lovastatin
Altoprev, Mevacor
Pravastatin
Pravachol
Pitavastatin
Livalo
Simvastatin
Zocor
Fluvastatin
Lescol
Atorvastatin
Lipitor
Rosuvastatin
Crestor
Low intensity statins
Simvastatin 10mg
Pravastatin 10-20mg
Lovastatin 20mg
Fluvastatin 20-40mg
Moderate intensity statins
Atorvastatin 10-20mg
Rosuvastatin 5-10mg
Simvastatin 20-40mg
Pravastatin 40-80mg
Lovastatin 40-80mg
Fluvastatin 40mg BID
Fluvastatin XL 80mg
Pitavastatin 1-4mgg
High intensity statins
Atorvastatin 40-80mg
Rosuvastatin 20-40mg
Lipophilic statins
Fluvastatin
Pitavastatin
Lovastatin
Simvastatin
Atorvastatin
Hydrophilic statins
Pravastatin
Rosuvastatin
Statin contraindications
Pregnancy, breastfeeding, acute liver disease
AEs of statins
Muscle myopathy/pain, increased creatine kinase
FLPs while using statins
Baseline test
4-12 weeks following tx initiation
Every 3-12 months prn
Bile acid resins (BARs)
Cholestramine
Colestipol
Colesevelam
Cholestyramine
Questran, Prevalite
Colestipol
Colestid
Colesevelam
WelChol
BAR AEs
Can increase TGs
GI side effects
Impaired absorption of fat-soluble vitamins
BAR may decrease effect of:
Warfarin
Digoxin
Oral contraceptives
Ezetimibe
Fibrates
Niacin
Niacor, Niaspan, Slo-Niacin
AEs of Niacin
Flushing, itching
Niacin contrainidications
Hepatic disease
Peptic ulcer
Arterial hemorrhage
Cholesterol absorption inhibitor
Ezetimibe
Ezetimibe + simvastatin
Ezetimibe
Zetia
Ezetimibe + simvastatin
Vytorin
Ezetimibe contraindications
Use with statin + hepatic disease
Pregnancy/breastfeeding w statin
Fibrates AEs
GI effects
Rash
Dizzy
Fibrates contraindications
Hx of gallbladder disease
Dialysis
Liver disease
Fibrates increase levels of:
Statins
Ezetimibe
Sulfonylureas
Warfarin
PCSK9 monoclonal antibodies
Alirocumab
Ecolocumab
Alirocumab
Praluent
Evolocumab
Repatha
PCSK9 dosing
Injectable dosage form
Can be dosing q2-4 weeks
PCSK9 should be considered for:
Stable ASCVD
High risk/statin intolerance
Further reduction of LDL after 1st tx
Inclisiran
Leqvio
Inclisiran AEs
Inj site reactions
UTI
URI
Diarrhea
Bronchitis
Inclisiran dosing
Injectable dosage form (prefilled syringe)
q6 months -> must be admin by HCP
Bempedoic acid
Nexletol, Nexlizet
Bempedoid acid AEs
URTI, muscle spasm, risk of tendon rupture
Avoid use with simvastatin and pravastatin
Red yeast rice
Active ingredient: lovastatin
Lomitapide
Juxtapid
Lomitapide warnings
BBW: hepatotoxicity
Must use REMS program
Evinacumab
Evkeeza
IV infusion